| The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells C Galustian, B Meyer, MC Labarthe, K Dredge, D Klaschka, J Henry, ... Cancer Immunology, Immunotherapy 58, 1033-1045, 2009 | 480 | 2009 |
| Immunotherapeutic potential of whole tumour cells S Ward, D Casey, MC Labarthe, M Whelan, A Dalgleish, H Pandha, ... Cancer Immunology, Immunotherapy 51, 351-357, 2002 | 178 | 2002 |
| Enhanced cross‐priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide JY Henry, MC Labarthe, B Meyer, P Dasgupta, AG Dalgleish, C Galustian Immunology 139 (3), 377-385, 2013 | 111 | 2013 |
| Thalidomide-derived immunomodulatory drugs as therapeutic agents C Galustian, MC Labarthe, JB Bartlett, AG Dalgleish Expert Opinion on Biological Therapy 4 (12), 1963-1970, 2004 | 73 | 2004 |
| Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer D Pellacani, RJ Packer, FM Frame, EE Oldridge, PA Berry, MC Labarthe, ... Molecular cancer 10, 1-14, 2011 | 53 | 2011 |
| Sodium accumulation in breast cancer predicts malignancy and treatment response AD James, TK Leslie, JD Kaggie, L Wiggins, L Patten, J Murphy O’Duinn, ... British journal of cancer 127 (2), 337-349, 2022 | 33 | 2022 |
| Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program AJ Taurozzi, R Beekharry, M Wantoch, MC Labarthe, HF Walker, RI Seed, ... PLoS One 12 (11), e0188228, 2017 | 24 | 2017 |
| The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model MC Labarthe, N Halanek, L Birchall, N Russell, C Desel, S Todryk, ... Cancer Immunology, Immunotherapy 55, 277-288, 2006 | 13 | 2006 |
| A novel murine model of allogeneic vaccination against prostate cancer MC Labarthe, P Theocharous, N Russell, S Todryk, C Bangma, P Thraves, ... Cancer Immunology, Immunotherapy 57, 453-465, 2008 | 10 | 2008 |
| Lenalidomide (Revlimid (R), CC-5013) and Actimid (TM)(CC-4047) inhibit the function and expansion of T regulatory (Treg) cells in vitro: Implications for anti-tumor activity in … C Galustian, DC Klaschka, B Meyer, MC Labarthe, JB Bartlett, ... CANCER RESEARCH 66 (8), 2006 | 8 | 2006 |
| The Immunomodulatory Drug (IMID®) CC-4047 Enhances the Proliferation and Anti-Tumor Function of Gamma Delta T Cells C Galustian, D Klaschka, MC Labarthe, JB Bartlett, AG Dalgleish Journal of Immunotherapy 27 (6), S50, 2004 | 4 | 2004 |
| The novel anti-cancer agent curcumin induces cytotoxicity in pancreatic cancer cell lines in vitro R Fryer, MC LaBarthe, A Dalgleish, C Galustian Cancer Research 68 (9_Supplement), 5673-5673, 2008 | 3 | 2008 |
| A novel murine model of allogeneic vaccination against renal cancer EG Havranek, MC Labarthe, S Ward, CJ Anderson, MA Whelan, ... BJU international 101 (9), 1165-1169, 2008 | 1 | 2008 |
| Thalidomide, lenalidomide and pomalidomide reduce the metastatic capability of cancer cells in vivo and in vitro W Liu, J Henry, B Meyer, MC Labarthe, J Bartlett, A Dalgleish, C Galustian Cancer Research 68 (9_Supplement), 1173-1173, 2008 | 1 | 2008 |
| Characterisation of intestinal dendritic cell populations in Helicobacter-induced colitis MC Labarthe, P Morrison, MC Kullberg IMMUNOLOGY 125, 85-85, 2008 | | 2008 |
| Development and study of whole cell vaccines in a novel mouse prostate model MC Labarthe St George's, University of London, 2004 | | 2004 |
| A novel marine model of allogeneic vaccination against prostate cancer. MC Labarthe, P Thraves, P Theocharous, A Dalgleish, M Whelan FASEB J 16 (4), A333-A333, 2002 | | 2002 |
| Utilising preclinical 23Na MRI to probe the ionic microenvironment of breast cancer: developing novel diagnostics to probe treatment efficacy. AD James, TK Leslie, MCBD Labarthe, M Nelson, F Riemer, G Baxter, ... | | |
| Progression towards in-vivo detection of Signal Amplification by Reversible Exchange (SABRE) Hyperpolarisation AJ Kennerley, MCBD Labarthe, EJ Fear, PJ Rayner, SB Duckett | | |
